Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT05184335
What this trial is testing

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Who this might be right for
Schizophrenia
Reviva Pharmaceuticals 690
Not applicableStudy completedNCT00823199
What this trial is testing

An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia

Who this might be right for
Schizophrenia
Bronx Psychiatric Center 10
Testing effectiveness (Phase 2)Study completedNCT00009048
What this trial is testing

EMD 128130 for the Treatment of Parkinson's Disease

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 30
Not applicableStudy completedNCT04260763
What this trial is testing

Evaluating a Novel Mobile App for Social Cognition in Psychosis

Who this might be right for
Schizophrenia; Psychosis
King's College London 14
Post-approval studies (Phase 4)Study completedNCT02188121
What this trial is testing

Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients

Who this might be right for
Serious Mental IllnessSchizophreniaSchizoaffective Disorder+4 more
Mclean Hospital 227
Not applicableLooking for participantsNCT05962216
What this trial is testing

Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders

Who this might be right for
PsychosisDepression
Dr. Albert Kar-Kin Chung 40
Post-approval studies (Phase 4)Study completedNCT06664138
What this trial is testing

Comparison of Remimazolam and Etomidate As Induction Agents for Electroconvulsive Treatment

Who this might be right for
Schizophenia DisorderMajor Depression DisordersSchizoaffective Disorder+1 more
Yeongseok Yun 30
Large-scale testing (Phase 3)Study completedNCT02335658
What this trial is testing

Long-term Study of DSP-5423P in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Sumitomo Pharma Co., Ltd. 200
Not applicableStudy completedNCT03208036
What this trial is testing

Restoration of Cognitive Function With TDCS and Training in Serious Mental Illness

Who this might be right for
SchizophreniaBipolar DisorderSchizo Affective Disorder
VA Office of Research and Development 22
Not applicableStudy completedNCT03527914
What this trial is testing

Patient Generated Goals in Mental Health: Better Outcomes?

Who this might be right for
Mental Health
Children's Hospital of Eastern Ontario 152
Early research (Phase 1)Study completedNCT00946348
What this trial is testing

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

Who this might be right for
SchizophreniaDual DiagnosisSchizoaffective Disorder+2 more
Dartmouth-Hitchcock Medical Center 12
Large-scale testing (Phase 3)Study completedNCT00249132
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen, LP 523
Large-scale testing (Phase 3)Study completedNCT00297947
What this trial is testing

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Manhattan Psychiatric Center 60
Large-scale testing (Phase 3)UnknownNCT02453893
What this trial is testing

Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia

Who this might be right for
Schizophrenia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 288
Large-scale testing (Phase 3)Study completedNCT01541371
What this trial is testing

Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 405
Testing effectiveness (Phase 2)Study completedNCT02810964
What this trial is testing

Sulforaphane to Reduce Symptoms of Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Sheppard Pratt Health System 64
Early research (Phase 1)Ended earlyNCT00929370
What this trial is testing

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Who this might be right for
Schizophrenia
GlaxoSmithKline 34
Not applicableUnknownNCT00825045
What this trial is testing

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Centre for Addiction and Mental Health 14
Testing effectiveness (Phase 2)Study completedNCT01649557
What this trial is testing

Multicenter, Open-label, Safety and Tolerability Study

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 244
Not applicableStudy completedNCT04166019
What this trial is testing

Effect of a Peer-led Self-management Program for Recent-onset Psychosis

Who this might be right for
Early PsychosisPsychotic Disorders
Chinese University of Hong Kong 180
Next Page